Clinical Trials Browser

Phase 1 × Weight Loss × irinotecan sucrosofate × Clear all

NCT03207724 2020-12-30

OnFX

Phase 1 Completed

Gastrointestinal

Adenocarcinoma, Cachexia, Disease, Pancreatic Neoplasms, Weight Loss